Ji-Liang Li

7PUBLICATIONS
9CO-AUTHORS
Biomolecular modelling and designMolecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2026
ROS-Activated Peptide-Based Prodrug for Chemoselective Covalent Targeting in Cancer Cells.

Shijin Zhang, Qinchuan Wei, Jiarong Lv

|Jul 03, 2023
Rationally Designed Enzyme-Resistant Peptidic Assemblies for Plasma Membrane Targeting in Cancer Treatment.

Shijin Zhang, Xuewen Gong, Qinchuan Wei

|Apr 27, 2022
Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy.

Yu-Feng Xiao, Bo-Sheng Li, Jing-Jing Liu

|May 06, 2021
Tspan5 promotes epithelial-mesenchymal transition and tumour metastasis of hepatocellular carcinoma by activating Notch signalling.

Qian Xie, Huiling Guo, Peirong He

|Aug 10, 2019
Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy.

Massimo Masiero, Demin Li, Pat Whiteman

|May 28, 2019
M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma.

Ningning Dong, Xiangyi Shi, Suihai Wang

Pageof 2

Frequent Collaborators

2 joint publications

Shijin Zhang

1 joint publications

Demin Li

1 joint publications

Jenny Greig

1 joint publications

Tasneem Hassanali